«Vaccines: Vac-Gen/Side Effects». Centers for Disease Control and Prevention. National Center for Immunization and Respiratory Diseases. Archivado desde el original el 17 de marzo de 2017. Consultado el 27 de marzo de 2017.
Patel, M; Lee, CK (25 de enero de 2005). «Polysaccharide vaccines for preventing serogroup A meningococcal meningitis.». The Cochrane Database of Systematic Reviews (1): CD001093. PMID15674874. doi:10.1002/14651858.CD001093.pub2. CD001093.
Conterno, LO; Silva Filho, CR; Rüggeberg, JU; Heath, PT (19 de julio de 2006). «Conjugate vaccines for preventing meningococcal C meningitis and septicaemia.». En Conterno, Lucieni O, ed. The Cochrane Database of Systematic Reviews (3): CD001834. PMID16855979. doi:10.1002/14651858.CD001834.pub2.
«Age-specific differences in duration of clinical protection after vaccination with meningococcal polysaccharide A vaccine». Lancet2 (8447): 114-18. 1985. PMID2862316. doi:10.1016/S0140-6736(85)90224-7.
«Reduced antibody response to revaccination with meningococcal serogroup A polysaccharide vaccine in adults». Vaccine19 (9–10): 1129-32. 2000. PMID11137248. doi:10.1016/s0264-410x(00)00317-0.
«Immune response to revaccination with meningococcal A and C polysaccharides in Gambian children following repeated immunization during early childhood». Vaccine17 (23–24): 3086-93. 1999. PMID10462244. doi:10.1016/S0264-410X(99)00139-5.
«Group A meningococcal carriage in travelers returning from Saudi Arabia». J Am Med Assoc260 (18): 2686-89. 1988. PMID3184335. doi:10.1001/jama.260.18.2686.
«Antibody persistence 3 years after immunization of adolescents with quadrivalent meningococcal conjugate vaccine». J Infect Dis193 (6): 821-8. 2006. PMID16479517. doi:10.1086/500512.
«Outer membrane vesicles of the VA-MENGOC-BC vaccine against serogroup B of Neisseria meningitidis: Analysis of protein components by two-dimensional gel electrophoresis and mass spectrometry». Proteomics6 (11): 3389-99. June 2006. PMID16673438. doi:10.1002/pmic.200500502.
Yih, Weiling Katherine; Weintraub, Eric; Kulldorff, Martin (1 de diciembre de 2012). «No risk of Guillain-Barré syndrome found after meningococcal conjugate vaccination in two large cohort studies». Pharmacoepidemiology and Drug Safety21 (12): 1359-1360. ISSN1099-1557. PMID23225672. doi:10.1002/pds.3353.
europa.eu
ema.europa.eu
«Nimenrix». European Medicines Agency. 24 de mayo de 2012. Consultado el 23 de diciembre de 2019.
Yih, Weiling Katherine; Weintraub, Eric; Kulldorff, Martin (1 de diciembre de 2012). «No risk of Guillain-Barré syndrome found after meningococcal conjugate vaccination in two large cohort studies». Pharmacoepidemiology and Drug Safety21 (12): 1359-1360. ISSN1099-1557. PMID23225672. doi:10.1002/pds.3353.
mshpriceguide.org
«Vaccine, Meningococcal». International Drug Price Indicator Guide. Archivado desde el original el 10 de mayo de 2017. Consultado el 6 de diciembre de 2015.
nbcnews.com
NBC News Digital (12 de noviembre de 2015). «Cuban scientist barred from receiving U.S. prize». Associated Press. Consultado el 27 de mayo de 2019. «A Cuban scientist who helped develop a low-cost synthetic vaccine that prevents meningitis and pneumonia in small children says he was offended the U.S. government denied his request to travel to the United States to receive an award.»
«Meningococcal vaccines : WHO position paper, November 2011». Wkly. Epidemiol. Rec.86 (47): 521-540. November 2011. PMID22128384. Resumen divulgativo.
Patel, M; Lee, CK (25 de enero de 2005). «Polysaccharide vaccines for preventing serogroup A meningococcal meningitis.». The Cochrane Database of Systematic Reviews (1): CD001093. PMID15674874. doi:10.1002/14651858.CD001093.pub2. CD001093.
Conterno, LO; Silva Filho, CR; Rüggeberg, JU; Heath, PT (19 de julio de 2006). «Conjugate vaccines for preventing meningococcal C meningitis and septicaemia.». En Conterno, Lucieni O, ed. The Cochrane Database of Systematic Reviews (3): CD001834. PMID16855979. doi:10.1002/14651858.CD001834.pub2.
«Age-specific differences in duration of clinical protection after vaccination with meningococcal polysaccharide A vaccine». Lancet2 (8447): 114-18. 1985. PMID2862316. doi:10.1016/S0140-6736(85)90224-7.
«Reduced antibody response to revaccination with meningococcal serogroup A polysaccharide vaccine in adults». Vaccine19 (9–10): 1129-32. 2000. PMID11137248. doi:10.1016/s0264-410x(00)00317-0.
«Immune response to revaccination with meningococcal A and C polysaccharides in Gambian children following repeated immunization during early childhood». Vaccine17 (23–24): 3086-93. 1999. PMID10462244. doi:10.1016/S0264-410X(99)00139-5.
«Group A meningococcal carriage in travelers returning from Saudi Arabia». J Am Med Assoc260 (18): 2686-89. 1988. PMID3184335. doi:10.1001/jama.260.18.2686.
Deeks, E.D (October 2010). «Meningococcal quadrivalent (serogroups A, C, w135, and y) conjugate vaccine (Menveo): in adolescents and adults.». BioDrugs4 (5): 72-6. PMID21270745.
«Antibody persistence 3 years after immunization of adolescents with quadrivalent meningococcal conjugate vaccine». J Infect Dis193 (6): 821-8. 2006. PMID16479517. doi:10.1086/500512.
Centers for Disease Control and Prevention (CDC) (January 2011). «Updated recommendations for use of meningococcal conjugate vaccines --- Advisory Committee on Immunization Practices (ACIP), 2010». MMWR Morb Mortal Wkly Rep60 (3): 72-6. PMID21270745.
Centers for Disease Control and Prevention (CDC) (September 2009). «Updated recommendation from the Advisory Committee on Immunization Practices (ACIP) for revaccination of persons at prolonged increased risk for meningococcal disease». MMWR Morb Mortal Wkly Rep58 (37): 1042-3. PMID19779400.
«Outer membrane vesicles of the VA-MENGOC-BC vaccine against serogroup B of Neisseria meningitidis: Analysis of protein components by two-dimensional gel electrophoresis and mass spectrometry». Proteomics6 (11): 3389-99. June 2006. PMID16673438. doi:10.1002/pmic.200500502.
Yih, Weiling Katherine; Weintraub, Eric; Kulldorff, Martin (1 de diciembre de 2012). «No risk of Guillain-Barré syndrome found after meningococcal conjugate vaccination in two large cohort studies». Pharmacoepidemiology and Drug Safety21 (12): 1359-1360. ISSN1099-1557. PMID23225672. doi:10.1002/pds.3353.
«Vaccine, Meningococcal». International Drug Price Indicator Guide. Archivado desde el original el 10 de mayo de 2017. Consultado el 6 de diciembre de 2015.
«Vaccines: Vac-Gen/Side Effects». Centers for Disease Control and Prevention. National Center for Immunization and Respiratory Diseases. Archivado desde el original el 17 de marzo de 2017. Consultado el 27 de marzo de 2017.